For COVID-19 and vaccination updates, view our information for the community. If you're experiencing symptoms, call your primary care provider.
Biodesix, Inc. BDX-00146
An observational study assessing the clinical effectiveness of the VeriStrat test and validation immunotherapy tests in subjects with non-small cell lung cancer
To collect information about how the study doctor uses the results of the VeriStrat blood test to choose treatment for NSCLC.
DiagnosisNon-small cell lung cancer.
No prior treatment necessary.
Patients must sign an approved informed consent and authorization permitting release of personal health information.
- There are no required treatments for this study, only blood draws and results.
- If EGFR gene status is unknown, additional blood will be drawn for testing.
Involvement in this study will last for 18 months.
For more information, visit ClinicalTrials.gov